Vous avez cherché: paaugstinata (Letton - Anglais)

zinama paaugstinata jutiba pret sulfanilamidiem.
known hypersensitivity to sulphonamides.

paaugstinata jutiba pret jebkuru preparata sastavdalu.
hypersensitivity to any of the constituents.

paaugstinata trombožu riska dēļ vēža pacientiem bieži tiek lietoti antikoagulanti.
due to the increased thrombotic risk in patients with cancer, the use of anticoagulation treatment is frequent.

paaugstinata jutiba pret kazas izcelsmes proteiniem vai kazas piena sastavdalam.
hypersensitivity to goat proteins or goat milk components.

ja jums ir alergija (paaugstinata jutiba) pret alfa antitrombinu vai jebkuru no atryn paligvielam.
do not use atryn if you are allergic (hypersensitive) to antithrombin alfa or any of the other ingredients of atryn.

ja celekoksibs tiek lietots vienlaikus ar preparatiem, kas ir ši enzima substrati, to koncentracija plazma var but paaugstinata.
the plasma concentrations of drugs that are substrates of this enzyme may be increased when celecoxib is used concomitantly.

� ja jums ir alergija (paaugstinata jutiba) pret šo insulfnu, metakrezolu vai kadu citu sastavda!u (skatft 7.
� if you are allergic (hypersensitive) to this insulin product, metacresol or any of the other ingredients (see 7 further information).

atryn terapijas merkis ir paaugstinat antitrombina aktivitati lidz 80– 120% (0, 8– 1, 2 sv/ ml) un uzturet to terapijas laika.
the therapeutic goal of treatment with atryn is to increase to, and maintain antithrombin activity between 80 – 120% (0.8 – 1.2 iu/ml) for the duration of treatment.